Source comparison
Semax Amidate: Nasal vs Injectable Comparison
Intranasal (0.1–1% solution) 70–80% CNS penetration 15–30 minutes 4–6 hours per dose Convenient, non-invasive, requires proper nasal technique to avoid throat drainage Preferred for most cognitive research applications. Rapid CNS access with minimal invasivene
This comparison does not assign a generated winner or score.
- Intranasal (0.1–1% solution)
- 70–80% CNS penetration
- 15–30 minutes
- 4–6 hours per dose
- Convenient, non-invasive, requires proper nasal technique to avoid throat drainage
- Preferred for most cognitive research applications. Rapid CNS access with minimal invasiveness
- Subcutaneous injection (reconstituted lyophilized powder)
- 90–95% systemic absorption
- 30–60 minutes
- 6–8 hours per dose
- Requires reconstitution, sterile technique, injection site rotation; more stable dosing
- Best for clinical/rehabilitation contexts requiring precise daily dosing without nasal irritation
- Oral (capsules or tablets)
- <5% (extensive first-pass degradation)
- N/A
- Peptidases in stomach and intestine cleave peptide bonds before absorption
- Not viable. Semax amidate is destroyed in GI tract before reaching circulation
- The intranasal route dominates research use because it combines high bioavailability with user-friendliness. Subcutaneous administration offers slightly better pharmacokinetic consistency but requires more preparation and comfort with self-injection protocols.